A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Manylion Llyfryddiaeth
Prif Awdur:	Shehab, Habibul Mohsin
Awduron Eraill:	Yasmin, Hasina
Fformat:	Traethawd Ymchwil
Iaith:	English
Cyhoeddwyd:	Brac University 2024
Pynciau:	Pharmacovigilance Rivastigmine Alzheimer's disease Dementia Pharmacoepidemiology. Mortality. Alzheimer's disease.
Mynediad Ar-lein:	http://hdl.handle.net/10361/22683

Eitemau Tebyg

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
gan: Tabassum, Nadira
Cyhoeddwyd: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
gan: Mahee, Sadique Abdal
Cyhoeddwyd: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
gan: Alim, Abdul
Cyhoeddwyd: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
gan: Karmaker, Swastika
Cyhoeddwyd: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
gan: Jahan, Nusrat
Cyhoeddwyd: (2023)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
gan: Ishrat, Nowshin
Cyhoeddwyd: (2024)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
gan: Bakar, Osama Bin Abu
Cyhoeddwyd: (2024)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
gan: Chowdhury, Sariya Uzrat
Cyhoeddwyd: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
gan: Islam, Md. Irfath
Cyhoeddwyd: (2023)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
gan: Saha, Bithi Rani
Cyhoeddwyd: (2023)

Alzheimer's disease and marriage : an intimate account /
gan: Wright, Lore K.
Cyhoeddwyd: (1993)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
gan: Hassan, Md. Muhtaz
Cyhoeddwyd: (2020)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
gan: Tasneem, Sadia
Cyhoeddwyd: (2021)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
gan: Tamanna, Mst. Taskia
Cyhoeddwyd: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
gan: Tasin, Md Abtahi
Cyhoeddwyd: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
gan: Aziz, Farhin
Cyhoeddwyd: (2019)

An ambient assisted living system for Alzheimer’s patients
gan: Abedin, Minhajul, et al.
Cyhoeddwyd: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
gan: Afra, Sumaiya
Cyhoeddwyd: (2022)

Marine compounds in the treatment of Alzheimer’s disease
gan: Parveen, Sanjana
Cyhoeddwyd: (2022)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
gan: Halim, Rabea
Cyhoeddwyd: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
gan: Aana, Afsara Sumon
Cyhoeddwyd: (2021)

Exploring Alzheimer's disease prediction with XAI in various neural network models
gan: Rahman, Quazi Ashikur, et al.
Cyhoeddwyd: (2022)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
gan: Mostofa, Golam
Cyhoeddwyd: (2022)

Gene editing for neurodegenerative diseases-A review
gan: Sharna, Anika Islam
Cyhoeddwyd: (2023)

A review on adult neurogenesis in Alzheimer’s disease
gan: Akter, Moriam
Cyhoeddwyd: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
gan: Zaman, Rubaiyat
Cyhoeddwyd: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
gan: Haque, Mushfiqul
Cyhoeddwyd: (2019)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
gan: Roy, Aditya, et al.
Cyhoeddwyd: (2023)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
gan: Dey, Manashi
Cyhoeddwyd: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
gan: Sani, Mehedi Hasan, et al.
Cyhoeddwyd: (2022)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
gan: Alam, Badrul, et al.
Cyhoeddwyd: (2016)

Role of circular RNA in neurological disease
gan: Salsabil, Labiba
Cyhoeddwyd: (2024)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
gan: Mahbub, Riasat, et al.
Cyhoeddwyd: (2022)

Skeleton /
gan: Parkin, Peter

A review on interrelation among post-authorisation study, regulatory action and pharmacogenetics in pharmacovigilance
gan: Nusrat, Tanzina
Cyhoeddwyd: (2019)

হার্ট, ব্লাড, ফুড /
gan: কাসেম, এম এ

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
gan: Rahman, Ahadina
Cyhoeddwyd: (2018)

Management of Diabetes patients during COVID-19
gan: Pantho, G. M. Golam Mehebub
Cyhoeddwyd: (2021)

Pharmacoepidemiology and pharmacovigilance : synergistic tools to better Investigate drug safety /
gan: Nour, Sabrina
Cyhoeddwyd: (2019)

Detection of alzheimer's disease using deep learning
gan: Hasan, Mahmudul, et al.
Cyhoeddwyd: (2021)